Show simple item record

dc.contributor.authorCrona, Jen
dc.contributor.authorLamarca, Angelaen
dc.contributor.authorRonot, Men
dc.contributor.authorOpalinska, Men
dc.contributor.authorLopez, Cen
dc.contributor.authorPezzutti, Den
dc.contributor.authorTrueba, Hen
dc.contributor.authorCarvhalo, Len
dc.contributor.authorde Mestier, Len
dc.contributor.authorNajran, Pavanen
dc.contributor.authorPavel, Men
dc.contributor.authorDromain, Cen
dc.date.accessioned2018-05-15T20:22:28Z
dc.date.available2018-05-15T20:22:28Z
dc.date.issued2018
dc.identifier.citationPre-treatment tumor growth rate (TGR0) in patients diagnosed with well-differentiated Neuroendocrine Tumors (NETs) treated with systemic therapies: subgroup analysis of the GREPONET study. 2018, 106: 171-171 Neuroendocrinologyen
dc.identifier.urihttp://hdl.handle.net/10541/621022
dc.language.isoenen
dc.titlePre-treatment tumor growth rate (TGR0) in patients diagnosed with well-differentiated Neuroendocrine Tumors (NETs) treated with systemic therapies: subgroup analysis of the GREPONET study.en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentDepartment of Medical Sciences, Uppsala University, Uppsala, Swedenen
dc.identifier.journalNeuroendocrinologyen


This item appears in the following Collection(s)

Show simple item record